Mirum Pharmaceuticals Inc (NAS:MIRM)
$ 41.56 -0.47 (-1.12%) Market Cap: 2.02 Bil Enterprise Value: 2.06 Bil PE Ratio: 0 PB Ratio: 8.69 GF Score: 51/100

Mirum Pharmaceuticals Inc Corporate Analyst Meeting Transcript

Dec 09, 2020 / 04:00PM GMT
Release Date Price: $24.02 (+0.67%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Mirum Pharmaceuticals Inaugural IR Day Virtual Program. (Operator Instructions) As a reminder, today's program may be recorded. And now I'd like to introduce your host for today's program, Ian Clements, Chief Financial Officer. Please go ahead, sir.

Ian Clements
Mirum Pharmaceuticals, Inc. - CFO

Thanks very much, indeed, and good morning, everybody. Welcome to Mirum's Inaugural Investor Relations Day. For those of you who don't know me, I'm Ian Clements, CFO at Mirum. I'm super excited to be here today and glad that you could all join us to be part of what I believe promises to be a great event.

Before starting, I would like to remind everybody that we will be making forward-looking statements today. So investors should read the risk factors set forth in Mirum's Form 10-K for the year ended December 31, 2019, and any subsequent reports filed with the Securities and Exchange Commission. So I do encourage you to visit the SEC website to see our latest filings.

Before turning

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot